December 30, 2016

New drug added to Alzheimer's study using novel PET tracer to track tau protein

“This novel radiopharmaceutical tracer – which is being developed by GE Healthcare and called THK-5351 – is designed to detect the brain protein tau by positron emission tomography (PET) scan. Tau accumulates in the brain of individuals with Alzheimer’s, where it forms toxic tangles,”  {read more here}